Lucira Health to Participate in Upcoming BofA Securities 2021 Virtual Healthcare Conference

Rhea-AI Summary

Lucira Health (Nasdaq: LHDX), a medical technology company, will participate in the BofA Securities 2021 Virtual Healthcare Conference on May 13, 2021, at 9:30 a.m. PT / 12:30 p.m. ET. The event will be accessible via a live and archived webcast on Lucira's investor page. Lucira specializes in innovative infectious disease test kits that deliver lab-quality results within 30 minutes using user-friendly, battery-powered devices. Their test kits, including the LUCIRA CHECK IT and LUCIRA COVID-19 All-In-One Test Kits, aim to provide reliable testing anywhere.

News Market Reaction – LHDX

-1.79%

-1.79% Session move

In the trading session that priced this news, LHDX declined 1.79%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

EMERYVILLE, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will be participating in the BofA Securities 2021 Virtual Healthcare Conference.

Lucira Health’s management is scheduled to participate in the conference on Thursday, May 13, 2021, at 9:30 a.m. PT / 12:30 p.m. ET. A live and archived webcast of the event can be accessed via the Investors page of the investor section of Lucira's website.

About Lucira Health
Lucira Health is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira’s testing platform produces lab quality molecular testing in a single-use, consumer-friendly, palm size test kit powered by two AA batteries. Lucira designed its test kits to provide accurate, reliable and on-the-spot molecular tests results anywhere and anytime. The LUCIRA CHECK IT (OTC) and LUCIRA COVID-19 All-In-One Test Kits (RX) are designed to provide a clinically relevant COVID-19 result within 30 minutes from sample collection. For more information, visit www.lucirahealth.com.

Investor Contact
Greg Chodaczek
Investorrelations@lucirahealth.com
347-620-7010

Media Contact
Kevin Knight
media@lucirahealth.com
206-451-4823

 

FAQ

When is Lucira Health participating in the BofA Securities Virtual Healthcare Conference?

Lucira Health will participate in the conference on May 13, 2021, at 9:30 a.m. PT / 12:30 p.m. ET.

Where can I access the Lucira Health conference webcast?

The live and archived webcast of Lucira Health's participation can be accessed via their investor page on their website.

What products does Lucira Health offer?

Lucira Health offers transformative infectious disease test kits, including LUCIRA CHECK IT and LUCIRA COVID-19 All-In-One Test Kits.

How quickly can Lucira Health's test kits provide results?

Lucira Health's test kits can provide clinically relevant COVID-19 results within 30 minutes from sample collection.

What is Lucira Health's stock symbol?

Lucira Health trades under the stock symbol LHDX on the Nasdaq.